All adults with type 1 diabetes should not routinely receive statin therapyNo abstract is available for this article.doi:10.1002/pdi.823Dr Peter H Winocour MD FRCP Consultant Physician and Honorary Senior LecturerEast and North Herts NHS Trust, UK...
Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycemia. It may be due to impaired insulin secretion, resistance to peripheral actions of insulin, or both. According to the International Diabetes Federation (IDF), approximately 415 million adults between the ages...
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to
And type 2 diabetes remission based on DiRECT is now very much in NHS England's plans? Yes, the speed of this comes as a surprise, because this is something NHS England has actually grasped and taken forward really, very rapidly. And so yes, that's very good. But at the heart of it...
1 2 3 4 5 Author : 伤口世界 David Morris There is strong evidence that early-onset type 2 diabetes (commonly defined as that occurring in people under the age of 40 years) is a more aggressive condition than late-onset type 2 diabetes. The lo...
From 840 patients in the cohort from the Israel Diabetes and Cognitive Decline Study, we identified 61 non-statin users and compared them with 45 patients who had used statins at least 90% of the time. Analysis of covariance was performed to compare mean cognitive z-scores between statin ...
However, whether the beneficial effect of fenofibrate on the endothelium is related to reduction of ADMA level in individuals with diabetes mellitus (DM) is not known, and the current study aimed to address this issue. Aim: A total of 60 patients with type 2 DM and dyslipidemia (aged 45 ...
Statin use and cognitive function in middle-aged adults with type 1 diabetes Karen A Nunley, Trevor J Orchard, Christopher M Ryan, Rachel Miller, Tina Costacou, Caterina Rosano Karen A Nunley, Trevor J Orchard, Christopher M Ryan, Rachel Miller, Tina Costacou, Caterina Rosano,Department of Ep...
Several hundred million people worldwide suffer from diabetes mellitus. While the majority of them have type 2 diabetes, also type 1 diabetes is a growing health problem in the Western world1. Roughly one third of individuals with type 1 diabetes develop chronic complications such as diabetic neph...
In summary, data from numerous studies convincingly demonstrate that people with diabetes are at increased risk of CHD, and gain as much relative benefit from statins as other high CHD-risk patients. However, statin therapy in these patients does not reduce their CHD risk to the same absolute ...